(Q33415914)

English

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

object named as

Antonio Calles

2

0 references

Josep Tabernero Caturla

object named as

Josep Tabernero

9

0 references

author name string

Irene Brana

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Patricia M LoRusso

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lorrin K Yee

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Thomas A Puchalski

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shobha Seetharam

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bob Zhong

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Carla J de Boer

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Emiliano Calvo

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

15 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Targeted oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

111-123

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Migratory Response of Human NK Cells to Monocyte-Chemotactic Proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Macrophages in tumor microenvironments and the progression of tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

CCL2 is a potent regulator of prostate cancer cell migration and proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Monocyte chemoattractant protein-1 serum levels in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.

1 reference

https://api.crossref.org/works/10.1007%2FS11523-014-0320-2

21 January 2018

Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24928772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24928772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24928772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11523-014-0320-2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33415914&oldid=2195340315"